Piperacillin plus vancomycin in the therapy of febrile episodes in cancer patients.

Piperacillin and vancomycin were used as initial empirical therapy for 211 febrile episodes in cancer patients. The response rate in 95 episodes of documented infection was 72%. The response of bacteremias, soft tissue infections, and pneumonias was 78, 71, and 38%, respectively. The response in inf...

Ausführliche Beschreibung

Bibliografische Detailangaben

Veröffentlicht in:	Antimicrob Agents Chemother
Hauptverfasser:	Jadeja, L, Bolivar, R, Fainstein, V, Keating, M, McCredie, K, Hay, M, Bodey, G P
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	American Society for Microbiology (ASM) 1984
Schlagworte:	Research Article
Online-Zugang:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC176155/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/6508260/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.26.3.295
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!